Citius Pharmaceuticals, Inc. (CTXR) Operating margin 2017–2022
Citius Pharmaceuticals, Inc. (CTXR) operating margin by fiscal year — reported operating income divided by reported revenue.
-37017.8%FY2022 · since FY2017: -19972.6% → -37017.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -37017.8% | -10871.3 pp |
| FY2021 | -26146.5% | -6468.0 pp |
| FY2020 | -19678.5% | -2347.0 pp |
| FY2019 | -17331.5% | +1054.0 pp |
| FY2018 | -18385.5% | +1587.1 pp |
| FY2017 | -19972.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CTXR financial trends
CTXR RevenueCTXR Net incomeCTXR Net marginCTXR Gross profitCTXR Gross marginCTXR Operating incomeCTXR Operating cash flowCTXR Free cash flowCTXR Capital expendituresCTXR Return on equityCTXR Stock buybacksCTXR Dividends paidCTXR Total assetsCTXR Total liabilitiesCTXR Shareholders’ equityCTXR overview →